Tata Consultancy Services Ltd Q3 FY2025 Concall Summary

Key Takeaways

• Strong TCV without mega deals: Total contract value hit \$10.2 bn, a Q3 record and double-digit YoY growth, achieved entirely through organic wins with no mega-deal contribution.
• Margins inched up despite seasonality: Operating margin rose 40 bps QoQ to 24.5%, as productivity and utilization gains offset furlough headwinds; the 26–28% aspiration band remains the target but not a near-term commitment.
• Discretionary spend is stirring, not surging: Early signs of revival in BFSI and Retail underpin cautious optimism for CY’25, but management concedes the recovery is not immune to a sharp macro deterioration.
• Agentic AI is the new growth thesis: TCS is pivoting from chatbots to transaction-orchestrating agents, using deep client context to design, train and deploy agents that solve high-value business problems.
• What to watch next quarter: Whether the BSNL ramp-down begins in Q4 or Q1, the pace of furlough recovery, and any policy clarity that unlocks Life Sciences & Healthcare discretionary spend.

Demand Environment

• Flat quarter, seasonal shape: Constant-currency revenue was flat sequentially, consistent with Q3 seasonality; YoY growth was 4.5% in constant currency.
• Where budgets are flowing: Client priorities center on cost optimization, business transformation, GenAI, AI and cloud services; technology modernization (SAP S/4HANA, cloud, data foundations for AI, cybersecurity) continues to draw strong investment.
• Deal cycles shortened: Compared to the prior quarter, deal cycles improved by a few weeks, which management flagged as a positive signal.
• Client budget outlook: CY’25 IT budgets are expected to remain similar to CY’24 with a positive bias; reprioritization will persist as clients seek ROI, but interest in discretionary projects is rising.
• The macro caveat: Early discretionary-spend revival gives confidence that CY’25 will be better than CY’24, but management acknowledged the recovery would not withstand a significant negative macro shock.

Krithivasan: "Yes, if the macro changes for the negative in a big way, that will impact. So, I don't think the discretionary spend will be visibly resistant to macro change."

Deal Wins & Order Book

A Q3 record without mega deals: TCV of \$10.2 bn was the highest for any Q3 since disclosure began, with double-digit YoY growth and no mega-deal contribution. North America TCV was \$5.9 bn, BFSI \$3.2 bn, and Consumer Business \$1.3 bn.

• Revenue conversion dynamics: Absence of mega deals means deal tenure could be marginally lower, but revenue realization could improve due to more discretionary work and greater certainty.
• BSNL 5G opportunity: BSNL has floated an RFP for a 5G upgrade; TCS qualifies and will participate.

Vertical Performance

• Recovery sequencing: Manufacturing is expected to bottom out in Q4 with growth reviving subsequently; Life Sciences & Healthcare recovery waits on US policy clarity; Retail outlook is better for CY’25, particularly in essential and fashion apparel sub-segments.
• Auto and aerospace: Challenges are transient (labor market, supply chain); some revival is slowly happening in North America; order books should drive growth as conditions stabilize.

AI & GenAI

Agentic AI: the next maturity step

• The shift: TCS is moving past the initial wave of chatbots and RAG deployments to agentic AI, which orchestrates actual transactions inside business value chains using the planning and reasoning capabilities of LLMs.
• The competitive moat: Deep contextual knowledge of customers’ businesses lets TCS design, train and deploy agents that solve high-value business problems, a capability clients struggle to build internally.

Production deployments

• American electronics retailer: Unified contact center platform using advanced NLU and conversational agents; supports 30,000 daily chat conversations, achieved 90% intent identification and 3% user containment improvement.
• Life sciences drug discovery: GenAI-based solution for identifying small molecules on a cancer target; generated 1,300 molecules optimized for five properties; 12 molecules shortlisted and in in vitro assessment.
• Global bank fraud detection: Predictive AI solution performing real-time transaction monitoring and anomaly detection; delivered 18 pp improvement in fraud detection, 25% reduction in false positives, 50% faster analysis response times.

AI infusion across the portfolio

• ignio: 30 new deal wins and 9 go-lives; AI/GenAI driving investments in AI-based systems and intelligent automation as customers pursue the autonomous enterprise journey.
• TCS iON: 38 new wins, 150-plus platform capabilities went live; growing demand for AI-driven analysis on assessed candidates’ data.
• Ongoing program: TCS is continuously infusing AI into every program (AMS, application development) for productivity and technology resilience.

Pricing and demand

• Net positive demand: Management assessed AI demand as net positive rather than negative, with customers using AI for both new projects (drug discovery, mainframe modernization) and productivity improvement.
• Pricing model unchanged: There has not been a significant change in TCS’s pricing model because of AI/GenAI at this time; most deals remain in traditional models.

Krithivasan: "Agentic AI represents the next step of maturity in the exponentially evolving space of AI. It allows us to orchestrate actual transactions inside business value chains using the rapidly improving planning and reasoning capabilities of large language models."

Margins

• The aspiration, not a commitment: Management’s margin aspiration remains 26–28%; the CFO said he would be happy to exit Q4 at 26% but has not committed to reaching it, and will strive to get as close to the guiding band as possible.
• Q4 trajectory: Management will push for improvement over and above Q3’s 40 bps.
• BSNL margin tailwind: On a like-to-like basis, as BSNL revenue declines, product mix becomes a margin lever going into FY’26.
• Capital allocation flexibility: Both buyback and dividend options remain available; the Board considers shareholder preferences and regulatory/tax changes. A special dividend of ₹66 per share was declared this quarter alongside the ₹10 interim dividend.

Seksaria: "margin aspiration remains 26% to 28%. I had not committed that we will reach 26% by Q4, what I said is we will be happy if we can exit Q4 at 26%."

People & Operations

• Headcount: Declined in Q3 due to seasonal optimization after significant additions in Q1 and Q2; management stated this is not a reflection of the demand environment.
• Promotions: Over 25,000 promotions awarded across levels in Q3; total promotions for the fiscal year exceed 110,000.
• Campus hiring: Program progressing as planned; preparations underway to onboard an increased number of campus hires next year.
• BSNL ramp-down: 70% complete; tapering could start in Q4 or Q1, possibly extending to a maximum of Q2.

Guidance & Commitments

Key Metrics